StevenMPincusMDPhD

Oncology • Saint Louis, MO

Associate Professor, Internal Medicine, St Louis University School of Medicine

Join to view full profile

Dr. Pincus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pincus' full profile

Already have an account?

Office
3655 Vista Ave
Saint Louis, MO 63110
Phone+1 314-577-6057

Fax+1 314-773-1167

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1987 - 1990
Emory University School of MedicineResidency, Internal Medicine, 1984 - 1987
Tulane University School of MedicineClass of 1983

Certifications & Licensure

MO State Medical License 1995 - 2025
IL State Medical License 2000 - 2002
PA State Medical License 1990 - 1998
MD State Medical License 1988 - 1991
LA State Medical License 1983 - 1990
American Board of Internal Medicine Internal Medicine

Clinical Trials

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting

Publications & Presentations

PubMed

2 citations
Esophageal Mycobacterium avium-intracellulare infection in a bone marrow transplant patient: Case report and literature review.
Rong Hou, Ravi P. Nayak, Steven M. Pincus, Jinping Lai, Louay Omran
Transplant Infectious Disease. 2019-02-01
3 citations
Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients.
M. Memon, M deMagalhaes-Silverman, Elana J. Bloom, John Lister, D. J. Myers
Bone Marrow Transplantation. 1995-01-01
59 citations
Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
John Lister, Witold B. Rybka, Albert D. Donnenberg, M deMagalhaes-Silverman, Steven M. Pincus
Clinical Cancer Research. 1995-06-01